5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide

C94H102N24O8 — CID 167583017

About 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide

5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide (PubChem CID 167583017) has the molecular formula C94H102N24O8 and a molecular weight of 1696.01 g/mol. Its IUPAC name is 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide.

Molecular Properties

• Compound Name: 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide
• PubChem CID: 167583017
• Molecular Formula: C94H102N24O8
• Molecular Weight: 1696.01 g/mol
• Exact Mass: 1694.83
• IUPAC Name: 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide
• SMILES: Cc1c(-c2nc3nccc(-c4ccc5c(c4)CCC[C@@H]5NC(=O)c4noc(C5(C)CC5)n4)c3[nH]2)cnn1C1CCOCC1.Cc1c(-c2nc3nccc(-c4ccc5c(c4)CCC[C@H]5NC(=O)c4noc(C(C)(C)C)n4)c3[nH]2)cnn1C(C)C.Cc1c(-c2nc3nccc(-c4ccc5c(c4)CCC[C@H]5NC(=O)c4noc(C5(C)CC5)n4)c3[nH]2)cnn1C1CCOCC1
• InChI: InChI=1S/2C32H34N8O3.C30H34N8O2/c2*1-18-24(17-34-40(18)21-9-14-42-15-10-21)27-36-26-23(8-13-33-28(26)37-27)20-6-7-22-19(16-20)4-3-5-25(22)35-30(41)29-38-31(43-39-29)32(2)11-12-32;1-16(2)38-17(3)22(15-32-38)25-34-24-21(12-13-31-26(24)35-25)19-10-11-20-18(14-19)8-7-9-23(20)33-28(39)27-36-29(40-37-27)30(4,5)6/h2*6-8,13,16-17,21,25H,3-5,9-12,14-15H2,1-2H3,(H,35,41)(H,33,36,37);10-16,23H,7-9H2,1-6H3,(H,33,39)(H,31,34,35)/t2*25-;23-/m101/s1
• InChIKey: HKWXLWYHMQLPMA-HEWGKDCBSA-N
• XLogP: 16.65
• TPSA: 400.69 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 26
• Rotatable Bonds: 17
• Heavy Atoms: 126
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	1696.01
LogP ≤ 5	16.65
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	26

Frequently Asked Questions

What is the IUPAC name of 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide?

The IUPAC name of 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide (CID 167583017) is 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide.

What is the SMILES notation for 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide?

The canonical SMILES for 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide is Cc1c(-c2nc3nccc(-c4ccc5c(c4)CCC[C@@H]5NC(=O)c4noc(C5(C)CC5)n4)c3[nH]2)cnn1C1CCOCC1.Cc1c(-c2nc3nccc(-c4ccc5c(c4)CCC[C@H]5NC(=O)c4noc(C(C)(C)C)n4)c3[nH]2)cnn1C(C)C.Cc1c(-c2nc3nccc(-c4ccc5c(c4)CCC[C@H]5NC(=O)c4noc(C5(C)CC5)n4)c3[nH]2)cnn1C1CCOCC1.

What is the InChIKey of 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide?

The InChIKey is HKWXLWYHMQLPMA-HEWGKDCBSA-N. The full InChI is InChI=1S/2C32H34N8O3.C30H34N8O2/c2*1-18-24(17-34-40(18)21-9-14-42-15-10-21)27-36-26-23(8-13-33-28(26)37-27)20-6-7-22-19(16-20)4-3-5-25(22)35-30(41)29-38-31(43-39-29)32(2)11-12-32;1-16(2)38-17(3)22(15-32-38)25-34-24-21(12-13-31-26(24)35-25)19-10-11-20-18(14-19)8-7-9-23(20)33-28(39)27-36-29(40-37-27)30(4,5)6/h2*6-8,13,16-17,21,25H,3-5,9-12,14-15H2,1-2H3,(H,35,41)(H,33,36,37);10-16,23H,7-9H2,1-6H3,(H,33,39)(H,31,34,35)/t2*25-;23-/m101/s1.

What are the key properties of 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide?

5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide has a molecular weight of 1696.01 g/mol, XLogP of 16.65, 17 rotatable bonds, 6 hydrogen bond donors, and 26 hydrogen bond acceptors.

Where does this data come from?

All data for 5-tert-butyl-N-[(1R)-6-[2-(5-methyl-1-propan-2-ylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1R)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide;5-(1-methylcyclopropyl)-N-[(1S)-6-[2-[5-methyl-1-(oxan-4-yl)pyrazol-4-yl]-1H-imidazo[4,5-b]pyridin-7-yl]-1,2,3,4-tetrahydronaphthalen-1-yl]-1,2,4-oxadiazole-3-carboxamide is sourced from PubChem (CID 167583017), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).